Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

0.2768
-0.0202-6.80%
Pre-market: 0.28280.0060+2.17%07:43 EDT
Volume:249.00K
Turnover:70.83K
Market Cap:5.57M
PE:-0.15
High:0.3000
Open:0.3000
Low:0.2739
Close:0.2970
52wk High:5.12
52wk Low:0.2604
Shares:20.12M
Float Shares:16.55M
Volume Ratio:0.67
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8267
EPS(LYR):-2.0700
ROE:-8585.26%
ROA:-56.19%
PB:-1.13
PE(LYR):-0.13

Loading ...

Vivos Therapeutics Names Roman Franklin CFO as Bradford Amman Resigns

Reuters
·
Aug 04

Vivos Therapeutics Discloses V-co Investors 4 as Beneficial Owner in Form 3 Filing

Reuters
·
Jul 16

Vivos Therapeutics price target lowered to 75c from $1.75 at Alliance Global

TIPRANKS
·
Jul 09

Vivos Therapeutics Creates New Series A Preferred Stock

TIPRANKS
·
Jul 08

Vivos Therapeutics Files Registration Statement for PIPE Warrant, Conversion Share Resales

Reuters
·
Jul 08

Vivos Therapeutics says Vida oral appliance improves insomnia in study

TIPRANKS
·
Jun 30

Vivos Says Study Shows Vida Oral Appliance Cuts Insomnia Severity in All 37 Patients

Reuters
·
Jun 30

Vivos Therapeutics Extends Debt-for-Equity Conversion Timeline

TIPRANKS
·
Jun 26

Vivos Therapeutics Extends Streeterville Debt-to-equity Conversion Deal Through Aug. 31, 2026

Reuters
·
Jun 26

Vivos Therapeutics Extends Financing Agreement With Streeterville Through August

MT Newswires Live
·
Jun 22

Vivos Therapeutics extends Streeterville deal to convert up to $4.5 million debt into equity

Reuters
·
Jun 22

Vivos Therapeutics - Streeterville Extends Agreement to Aug 31, 2026, Reaffirms $4.5 Mln Debt Conversion Commitment

THOMSON REUTERS
·
Jun 22

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

THOMSON REUTERS
·
Jun 22

Vivos Therapeutics Plans Rights Offering to Existing Shareholders

TIPRANKS
·
Jun 17

Vivos Therapeutics plans registration statement for transferable shareholder rights offering

Reuters
·
Jun 17

Vivos Therapeutics partners with South Palm Cardiovascular to launch Florida sleep apnea, insomnia services venture

Reuters
·
Jun 16

Vivos Therapeutics Plans to File for Proposed Rights Offering

MT Newswires Live
·
Jun 11

Vivos Therapeutics plans SEC registration filing for proposed transferable rights offering

Reuters
·
Jun 11

Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering

THOMSON REUTERS
·
Jun 11

Vivos Therapeutics enters pact with South Palm Cardiovascular Associates

TIPRANKS
·
Jun 10